folclorejogo Ozempic Can Curb Drinking, New Research Shows

data de lançamento:2025-03-28 06:22    tempo visitado:184

Some people who take drugs like Ozempic have noticed a surprising but welcome side effect: They drink less.folclorejogo

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It found that semaglutide, the substance in Ozempic and the weight loss drug Wegovy, could in fact help curb alcohol cravings. It is the first randomized controlled trial on semaglutide and alcohol consumption.

The study followed 48 adults who met criteria for alcohol use disorder, a condition often characterized by difficulty controlling alcohol consumption. Half of the patients took low doses of semaglutide, and half received placebo shots. The participants spent two hours in a lab room stocked with their preferred alcoholic beverages — once before they started taking the drug, and once after. People in the study also reported how much they drank every day for nine weeks.

Those who took semaglutide still drank about as often as those who took the placebo. But by the second month of the study, people taking semaglutide were drinking nearly 30 percent less, on average, on days they consumed alcohol — compared to an average reduction of about two percent in the placebo group. People who took semaglutide were also more likely to report fewer days of heavy drinking than those on the placebo, and to say that their cravings for alcohol had diminished.

The effects on alcohol consumption were larger than the researchers anticipated, given previous data on other medications for alcohol use disorder, said Christian Hendershot, director of clinical research at the University of Southern California Institute for Addiction Science and the lead author on the study.

There has been so much research on drugs like semaglutide and alcohol,66jogo.com “you can’t even keep up,” said W. Kyle Simmons, a professor of pharmacology and physiology at Oklahoma State University who is currently conducting a trial on the medication’s effects on alcohol use disorder.

We are having trouble retrieving the article content.

On Friday, Ms. Harris will stop along a stretch of that 2,000-mile dividing line in the political battleground of Arizona, directly confronting an issue that polls show remains a major weakness for her. It will be her first visit to the border as a presidential candidate, and her first since 2021, when she was given the diplomatic mission of tackling the root causes of migration from Guatemala, Honduras and El Salvador.

But they have serious flaws. Weight gain, a common side effect, contributes to a high rate of cardiac disease and early death among people with schizophrenia. And many patients stop taking the medications, complaining that they leave them sluggish and unmotivated.

Please enable JavaScript in your browser settings.

Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.

Thank you for your patience while we verify access.

365jdb

Already a subscriber? Log in.

Want all of The Times? Subscribe.folclorejogo